RA
PBH icon

Rise Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Rise Advisors’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-127
Closed -$7.92K – 1051
2025
Q3 		$7.92K Hold
127
– – ﹤0.01% 1087
2025
Q2 		$10.1K Hold
127
– – ﹤0.01% 989
2025
Q1 		$10.9K Sell
127
-28
-18% -$2.3K ﹤0.01% 909
2024
Q4 		$12.1K Hold
155
– – 0.01% 928
2024
Q3 		$11.2K Hold
155
– – 0.01% 984
2024
Q2 		$10.7K Hold
155
– – 0.01% 991
2024
Q1 		$11.2K Buy
+155
New +$10.4K 0.01% 1026

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rise Advisors's PBH Position: Q4 2025 in Review

Rise Advisors sold out of Prestige Consumer Healthcare (PBH) in Q4 2025, closing a stake of 127 shares — an estimated $7.92K sold.

Rise Advisors first reported a position in PBH in Q1 2024 and held it in 7 quarters. The position peaked at $12.1K in Q4 2024. 354 funds tracked by Wall St. Rank hold PBH as of Q4 2025.

  • Rise Advisors reported no remaining Prestige Consumer Healthcare position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 127 Prestige Consumer Healthcare shares in Q4 2025, an estimated $7.92K.
  • Rise Advisors first reported a position in Prestige Consumer Healthcare in Q1 2024 and held it in 7 quarters.
  • Rise Advisors's Prestige Consumer Healthcare position peaked at $12.1K in Q4 2024.
  • 354 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.